Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA in rapidly dividing cells refers to the genomic material that is actively undergoing replication as part of the cell cycle. During processes like tissue growth and repair—or more pathologically during cancer—cells must duplicate their entire genome before division. This makes replicating DNA a critical vulnerability in fast-growing tumors and other hyperproliferative conditions. Therapeutically, many anti-cancer drugs exploit this vulnerability by targeting either the structure of replicating DNA itself or the proteins involved in its synthesis and maintenance. For example, certain regions within the genome can form secondary structures such as G4 quadruplexes that impede replication; these have been identified as potential drug targets[1]. More broadly, agents that interfere with enzymes required for unwinding or copying DNA can selectively kill rapidly dividing cells but also affect normal tissues with high turnover rates[5][7]. While "DNA in rapidly dividing cells" is not a single molecular entity like an enzyme or receptor but rather a functional state of cellular nucleic acid during S phase of the cell cycle[6], it remains a central concept for understanding how many chemotherapeutics achieve selectivity for cancer over non-dividing tissues. Note: The designation "DNA in rapidly dividing cells" is imprecise from a molecular pharmacology perspective—it describes a process/state rather than an individual molecule/protein target. Therefore, *is_incorrect* = true; this entry should be mapped more specifically to components such as "DNA polymerase," "topoisomerase," "replication fork complex," etc., depending on context. However, it remains widely used when discussing general mechanisms underlying classic cytotoxic chemotherapy[5][7].
Inhibition of DNA replication enzymes or machinery to induce replication stress and cell death[5][7] - Induction of double-strand breaks or crosslinking to prevent proper genome duplication[1][5]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA in rapidly dividing cells.